phase readout
saveNCT05335941: A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Urothelial Carcinoma, Metastatic Cancer
view source ↗
comments(0)
5-min edit window · permanent after that